A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps - Scorecard - MDSpire
Advertisement
A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps
Clinical Scorecard: Evaluating Disease-Free Survival in Triple-Negative Breast Cancer Through Habitat Analysis of Preoperative DCE-MRI Subtraction Maps
At a Glance
Category
Detail
Condition
Triple-Negative Breast Cancer
Key Mechanisms
Assessment of intratumoral heterogeneity using DCE-MRI subtraction maps.
Target Population
Patients with pathologically confirmed triple-negative breast cancer.
Care Setting
Retrospective analysis in a clinical research environment.
Key Highlights
145 patients with TNBC were enrolled; 29 experienced recurrence.
Higher habitat intratumoral heterogeneity (ITH) was observed in high-risk recurrence group.
Habitat ITH was identified as an independent predictor of poorer disease-free survival (DFS).
ROC curve analysis showed AUC of 0.71 for habitat ITH in predicting recurrence.
Guideline-Based Recommendations
Diagnosis
Use DCE-MRI subtraction maps to assess tumor heterogeneity.
Management
Consider habitat analysis for prognostic evaluation in TNBC.
Monitoring & Follow-up
Monitor intratumoral heterogeneity as a potential indicator of recurrence risk.
Risks
High intratumoral heterogeneity is associated with increased likelihood of recurrence.
Patient & Prescribing Data
Patients diagnosed with triple-negative breast cancer.
Habitat analysis may guide individualized therapeutic decisions.
Clinical Best Practices
Implement noninvasive imaging methods for assessing tumor heterogeneity.
Utilize habitat analysis to improve prognostic stratification in TNBC.
